Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3737_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
27 Мб
Скачать
Multimodality Imaging ofRight Ventricular Outow Tract Disease inAdults withCongenital Heart Disease
https://t.me/med1917
139
tension. Historically as neonates grew and the PAs increased to sufcient size, “complete” repair became possible. This procedure generally includes patch repair of the VSD, resection of the RVOT obstruction, and occasional PA augmenta­tion [4, 6]. Current trends are toward early repair with valve-sparing techniques and a general avoidance of palliative shunting.
The initial technique of “complete” repair included resection of as much tissue as necessary for full relief of RVOT obstruction. RVOT aug­mentation was then required with a transannular patch. The latter resulted in varying degrees of pulmonic insufciency, which generally increased over time as the RV and RVOT remod­eled. Longstanding and signicant pulmonic regurgitation (PR) can lead to RV failure and is a signicant source of morbidity and mortality [4,
5]. In the absence of severe pulmonary annular
hypoplasia, the surgical approach today is trans­atrial/trans-pulmonary incision with closure of VSD and relief of RVOT obstruction using valve sparing techniques, recognizing residual obstruc­tion is better tolerated (with regression over time) than regurgitation. In other variants of TOF where the pulmonary arterial tree is hypoplastic, valved RV-PA conduits can be used to provide adequate antegrade ow [2, 3, 6]. Patients with pulmonic atresia and intact ventricular septum have a severely atretic pulmonic valve with circu­lation dependent on the presence of a patent duc­tus arteriosus and/or an interatrial communication. These patients also have variable degrees of right ventricular and tricuspid valve hypoplasia that complicate the pursuit of complete biventricular repair. During infancy, palliation centers around promotion of pulmonary blood ow. This is achieved via prostaglandin infusions and inter­ventions such as surgical shunts and ductal stents. In the absence of right ventricular dependent coronary ow, decompression is achieved by pul­monary valvotomy with or without transannular repair. For patients who have right ventricular dependent coronary ow or if the right ventricle remains hypoplastic and diminutive despite decompression, a single ventricle surgical repair strategy is often employed. In patients with a suf­cient RV and tricuspid valve, the RVOT is
reconstructed using a transannular patch, the ASD is closed, and valvotomy is performed. These patients, similar to TOF repaired by trans­annular patch, undergo repeated PV interventions [2, 3].
In infants with critical isolated pulmonic ste­nosis (PS), cyanosis is common as the ductus arteriosus begins to close in the rst few hours of life and elevated right sided pressures result in right-to-left shunting across the foramen ovale. The anatomy is often described as a dome-shaped valve with commissural fusion, or a dysplastic valve with thickened leaets [2, 7]. For those infants with severe symptoms, a peak gradient 40 mmHg and ductal dependency, catheter based valvuloplasty provides a bridge to deni­tive surgical intervention later in infancy. While valvuloplasty works well for domed valves, it is less successful for thickened, dysplastic valves, where surgical intervention is usually required [8]. Surgical technique is dependent on the degree of annular hypoplasia. In the absence of severe annular hypoplasia, incision of the commissures may increase valve area; while severe annular hypoplasia and supravalvular stenosis require techniques used in TOF repair, including transan­nular patching and PA augmentation [2, 6]. Despite good durability, complications like those seen in TOF occur, [5] including RVOT obstruc­tion, PR, and endocarditis.
For patients with PS, follow-up with Adult Congenital Heart Disease (ACHD) providers depends on symptoms and clinical status, with imaging performed as frequently as every 1–5 years depending on lesion severity [9]. Severity in PS is graded similarly to aortic steno­sis. Mild PS is identied by a peak veloc­ity <3 m/s and severe PS with a peak velocity >4 m/s. Indications for intervention include at least moderate PS (3 m/s velocity) with exertional limitation, cyanosis, or heart fail­ure. RVOT obstruction uses the same velocity criteria and intervention is indicated for patients with at least moderate obstruction of a RV-PA conduit if there is a decline in functional status or increased burden of arrhythmias [9, 10]. For patients with PR, either after management of iso­lated PS or after repair of TOF, intervention is
140
https://t.me/med1917
T. Spates and R. A. Krasuski
recommended for at least moderate PR and asso­ciated symptoms. If the patient is sedentary, exer­cise testing can be helpful to uncover functional limitation. Quantitative assessments with imag­ing can identify a Class IIa indication for valve replacement. Moderate PR associated with sig­nicant RV dilation by cardiac magnetic reso­nance imaging (cMRI) volumes, RV dysfunction or LV dysfunction, or associated moderate or
namic assessment, close monitoring of radiation exposure is essential for young adults with CHD. Given concerns regarding lifetime radia­tion exposure, alternative imaging modalities should be considered whenever possible. cMRI is ideal for patients who require close monitoring of ventricular volumes given the lack of radiation exposure; thereby justifying its Class I recom­mendation [911, 14].
greater tricuspid regurgitation (TR) are indications for PV replacement, as is RVOT obstruction with RVSP 2/3 systemic pressure. If there are no additional pathologies that require surgical intervention, a transcatheter approach should be considered [9, 10].
In patients with extensive surgical histories and the presence of bioprosthetic material, limit­ing the risk of systemic infection is paramount. The ACC/AHA Guidelines recommend antibi­otic prophylaxis in patients with prosthetic valves, a prior history of endocarditis, the pres­ence residual shunts at sites of prior repair, his­tory of uncorrected cyanotic heart disease, or recent intervention using prosthetic material in the last 6 months. Should patients present with concerns for systemic infections, blood cultures and dedicated cardiac imaging are required to evaluate for the presence and extent of endocardi­tis [9, 11].
Surveillance for long-term complications from RVOT pathology is necessary and often uti­lizes a multi-modality approach. Echocardiography is the rst-line tool used to delineate anatomy as justied by appropriate use
transthoracic, transesophageal, and ICE. Chest wall imaging is the main modality used for sur­veillance in repaired CHD, but can be limited by poor imaging windows (body habitus and lung disease) and artifact from prosthetic material. Sedated intraprocedural transesophageal echo or ICE can eliminate such artifacts. RV dysfunction is dened by echo as a fractional area change <35%, or diminished tricuspid annular excursion as measured by TAPSE and S velocity [12]. For patients with prior pulmonic interventions or prosthetic PVs, visualization of the RVOT or PV can be challenging. While grading obstruction and stenosis of the RVOT or PV is more direct, quantitative assessment of PR is more challeng­ing. Severity of PR is delineated by jet width, jet density, regurgitant volume and regurgitant frac­tion. Mild PR is characterized by a regurgitant jet width<20% of annular diameter, an incomplete continuous wave Doppler envelope and a regur­gitant fraction <20%. Severe PR is characterized by jet width>40% of annular diameter, dense and complete continuous wave Doppler envelope and
regurgitant fraction >40% [12, 15]. criteria and is routinely used for the evaluation of structural complications [12, 13]. The AHA/ACC Guidelines recommend the use of additional imaging for more quantitative ventricular assess­ment or a detailed reconstruction of vascular anatomy [10, 14]. Other imaging modalities include cMRI, CCT, and right heart catheteriza­tion (RHC), which can provide hemodynamic, uoroscopic and intracardiac echo (ICE) evalua­tion. While imaging modalities like CCT and RHC can provide anatomical detail and hemody-
vide vascular, volumetric and structural detail.
An advantage of CCT is shorter scan times than
cMRI, at the price of ionizing radiation exposure
and the need for contrast media administration.
While it is possible to create anatomic three-
dimensional reconstructions using either CCT or
cMRI, CCT is generally favored due to higher
spatial resolution. Reconstructions facilitate pre-
procedural planning, including the selection of
appropriate devices [11, 14, 16] (Fig.1).
Two-dimensional echocardiography includes
Multi-detector CCT with ECG gating can pro-
Multimodality Imaging ofRight Ventricular Outow Tract Disease inAdults withCongenital Heart Disease
https://t.me/med1917
141
Fig. 1 Cardiac CT of our patient demonstrating a multi-planar reconstruction with short axis, four chamber and 2 chamber view of the left ventricle with volume rendered image
cMRI has emerged as an essential component for the follow-up of patients with congenital heart diseases and is especially valuable in assessing the RV, RVOT and PV.The AHA/ACC Guidelines give a Class I recommendation for cMRI if RV volumes are required to guide man­agement. Quantitative assessment of RVEF can be performed using steady state free precession (SSFP) cine imaging and volumetric calculation, [5] with RV dysfunction dened as an RVEF <50%. Ventricular volumes are indexed to body surface area. Thresholds for intervention in pul­monic regurgitation include an RVEDVI
160mL/m2, RVESVI ≥80mL/m2, or RVEDV ≥2 × LVEDV [9, 10, 14, 17] (Figs.2, 3 and 4).
Quantication of PS and PR severity can be performed by velocity encoding phase contrast imaging. This sequence assesses the velocity of protons in a particular region in relation to a
technician- specied velocity. If that region of interest aliases, it indicates the velocity exceeds that preset parameter. This same modality can not only interrogate stenoses, but also quantify regur­gitation by assessing ow during systole and diastole. Velocity encoded imaging is most accu­rate when interrogating laminar ow. Occasionally velocities can signicantly overes­timate or underestimate gradients when the regurgitation is eccentric or turbulent. Regurgitant lesions can also be quantied using the volumet­ric assessments for LV and RV stroke volumes in the absence of any confounding regurgitant lesions [14].
Each imaging modality has inherent limita­tions. Thus, the use of multiple modalities can provide more complete assessment of anatomy and hemodynamics, more accurately guiding clinical management (Fig.5).
142
https://t.me/med1917
T. Spates and R. A. Krasuski
Fig. 2 Short axis slices of the ventricles used for visual assessment and volumetric quantication of ventricular func­tion using SSFP cine imaging
Multimodality Imaging ofRight Ventricular Outow Tract Disease inAdults withCongenital Heart Disease
https://t.me/med1917
Fig. 3 Dedicated views of the LV using SSFP cine imaging
143
Fig. 4 Dedicated views of the RV using SSFP cine imaging
144
https://t.me/med1917
Fig. 5 Adapted table of appropriate use criteria for multimodality imaging for specic congenital anatomies [13]
T. Spates and R. A. Krasuski
Diagnosis andPre-procedural Evaluation
The patient had been followed in the Adult Congenital Heart Disease Clinic at ~6-month intervals, with his sole complaint being intermit­tent lower extremity edema that usually responded well to diuresis. Routine echocardiography revealed grossly normal biventricular function with mild TR, trivial PR and moderate PS with a peak velocity of 3.1m/s (Fig.6).
The patient returned to clinic frequently over the course of the next year with complaints of increasing lower extremity edema, shortness of breath, and progressively lower oxygen satura­tion. His diuretic regimen was increased fre­quently with intermittent improvement. Given his progressive symptoms, a cMRI was performed.
Calculated LVEF was 67% and RVEF was 45%, with evidence of RV pressure and volume
overload. Imaging further demonstrated regional akinesis of the infundibular region with adherence to the sternum. The RVOT patch was stable and there was no evidence of residual VSD.Moderate PR was present, although the regurgitant fraction measured only 19%. The regurgitant jet was tur­bulent in appearance, with peak velocity measur­ing 3.2m/s, consistent with moderate PS.Because the data were largely unchanged from his prior study, routine follow- up at 6months was planned (Figs.7 and 8).
At follow-up ~6months later, the patient was profoundly dyspneic and required direct admis­sion to the cardiovascular intensive care unit for hypoxic respiratory failure, volume overload, and systemic hypotension. A RHC was performed and revealed a transpulmonary peak-to-peak gra­dient of 31 mmHg at the level of the valve (Fig.9).
Aggressive diuresis was continued and the need for PV intervention were discussed.
Multimodality Imaging ofRight Ventricular Outow Tract Disease inAdults withCongenital Heart Disease
https://t.me/med1917
145
Fig. 6 Peak velocity in the RVOT of 3.1m/s measured at the level of the PV
Fig. 7 Volumetric
assessment to determine LV volumes and function, which were normal. Note the RV stroke volume exceeds that of the LV, consistent with a regurgitant valve and increased RVEDV
146
https://t.me/med1917
Fig. 8 Velocity encoded phase contrast imaging at the level of main PA revealing a peak velocity of 3.2m/s. Note the reversal of ow below the baseline, which represents signicant regurgitation
T. Spates and R. A. Krasuski
Multimodality Imaging ofRight Ventricular Outow Tract Disease inAdults withCongenital Heart Disease
https://t.me/med1917
Fig. 9 RHC demonstrates a~31mmHg peak-to­peak gradient across the pulmonic valve and elevated pulmonary capillary wedge pressure consistent with at least moderate PS and concomitant left ventricular diastolic dysfunction. Of note, the patient was given moderate sedation, which could reduce cardiac output and lead to gradient underestimation
147
Heart Team Approach andDiscussion
Based on admission for decompensated HF and evidence of RV dysfunction with at least moder­ate PS and/or PR, the patient met a Class I indica­tion for PV intervention based on 2018 AHA/ ACC Guidelines for Management of ACHD [9,
10] (Figs.10 and 11).
Surgical and transcatheter valve replacement options were considered with the patient. Given his respiratory limitation (chronic hypercarbia and hypoxemia), the proximity of RV free wall to sternum, and his advanced clinical status, the decision was made to pursue transcatheter valve implantation.
There are two types of transcatheter pulmonic prostheses currently available, balloon expand-
148
https://t.me/med1917
Fig. 10 Modied table regarding general indications for intervention in PR in repaired TOF [2, 9, 10]
Fig. 11 Modied table regarding strength of recommendations for intervention in repaired TOF [2, 9, 10, 17]
T. Spates and R. A. Krasuski
able and self-expanding platforms/valves. Balloon expandable valves were rst developed for deliv­ery into conduits and bioprostheses, which serve as ideal landing zones. The two FDA approved balloon expandable valves are the Melody (Medtronic, Minneapolis, MN) and Sapien (Edwards Lifesciences, Irvine, VA) valves. These valves are generally not able to be delivered into patch-repaired outow tracts as they are limited in size by the balloon expandible system, with the Melody Valve sized from 18–22 mm and the Sapien Valve from 20–29mm. Prior to implanta­tion, proper sizing is essential, as is intraproce­dural balloon compression testing to ensure no distortion of the aortic or coronary anatomy [18].
Self-expanding devices include the Harmony Valve (Medtronic, Minneapolis, MN) and the Alterra Adaptive Prestent (Edwards Lifesciences, Irvine, VA), the latter of which is used in concert with the 29 mm Sapien S3 Valve (Edwards Lifesciences, Irvine, VA). These devices can expand to much larger sizes without risk for coro­nary or aortic compression. Neither device by design, however, treats stenosis. For both devices, pre-procedural RVOT assessment is required using a specialized CT scan shared with the respective company to assess candidacy, model the valve implant and determine the ideal landing zone [18].
Intra-procedural Imaging
The patient underwent cardiac catheterization with a plan for RVOT augmentation via stenting followed by placement of a transcatheter pul­monic valve.
Prior to proceeding, the operator ensures absence of coronary artery or aortic compression by inating a high-pressure balloon across the RVOT/MPA during aortography or selective cor­onary angiography.
With no coronary artery compression or aortic deformation, the operators proceeded with stent placement [14]. After two stents were deployed (to provide increased radial strength), free PR was present as expected. The stent was further expanded by post-dilatation to ensure an ade­quately sized delivery zone for the transcatheter valve (Figs.12 and 13).
A 23mm Sapien S3 valve was then delivered into the pulmonic position. Mild residual narrow­ing was still present at the completion of the case, secondary to conduit calcication and external compression, though the transpulmonary gradi­ent was reduced to only 2mmHg (Fig.14).
An echocardiogram was performed post­procedurally and revealed no evidence of steno­sis or regurgitation (Fig.15).